Karim Touijer
@TouijerKarim
Followers
1K
Following
265
Media
22
Statuses
244
Incredible time in @UroTarget with high level discussions around HSPC / CRPC role of PET-PSMA / 177Lu-PSMA together with @TouijerKarim @DoctorSotelo @fedelosco @AndreaMarchioni Mack Roach Past, present and future with new RLT options!! @UroTeragLATAM @mflazzaro_gu
0
3
4
WE ARE READY! UroTarget 2025 10y Edition The LATAM meeting of uro-oncology
3
7
21
UROTARGET 10 años - Mendoza 2025 Imágenes de la segunda jornada
0
2
3
Un gran evento de oncología GU
@UroTarget @cdanicas @TouijerKarim @DrSotelo01 @DrFelixGuerrero @g_develasco @fedelosco @mflazzaro_gu @Martin_AngelMD Orgulloso y feliz de hacer parte de este gran evento! Gracias por la invitación!
0
0
3
Congratulations
0
0
4
Thank you for sharing: food for thought
Palabras sobrias, reflexión serena y necesaria. Hacia donde queremos ir?
0
0
2
Palabras sobrias, reflexión serena y necesaria. Hacia donde queremos ir?
2
3
19
For the 3rd consecutive year MSK- Urology is the number 1 urology service by the U.S. News & World Report. Congratulations to our doctors, nurses, PAs, admin staff and everyone in the clinical care team. To our patients, thank you for your trust @UrologyMSK
3
2
52
A comment on some invalid criticisms of the radical prostatectomy lymph node dissection trial
0
1
5
Confirmation of the results of our RCT showing that PLND reduces metastasis without affecting BCR. @UrologyMSK @Uroweb @EUplatinum @JUrology @VickersBiostats #prostatecancer
4
19
93
Congratulations Mark well deserved
0
0
1
#UROonco25 great clinical case discussion on practical implications of PSMA PET CT for upfront staging in a man with unfavorable intermediate-risk: consider all variables! @TouijerKarim @ZilliThomas @Albert0Briganti @roodvdb @GertMeerleer @CfSpic @GGandaglia @JGomezRivas @Uroweb
1
4
33
PLND is a valuable part of radical prostatectomy. Great clinical trials are ongoing…
@TouijerKarim @Uroweb So tonight we will eventually know whether we still have to do PLND or not, right? @Tilki_De @Uroweb #UROonco25
1
0
15
Starting today Uro-Onco 2025 of the @Uroweb with great rapid fire debates and state of the art lectures on pertinent topics in uro-Oncology https://t.co/MI46g1yneB
1
1
21
We are thrilled to announce our @UroOnc match results! Welcome to @MSKCancerCenter and congratulations to all the other applicants!
0
15
137
Great distinction from @EUplatinum for our trial on pelvic lymph node dissection in #prostatecancer . Gratitude to the patients who participated in the trial and my @UrologyMSK colleagues. Moving forward together towards finding answers to important questions in cancer care.
5
11
92
First Urological rider cup just finished. Amazing debate! Big thank you @DrDeanElterman @karim @AntonioAlcarazA @RecordatiEspana @dperfen i enjoyed so much! Next year more and better
0
6
30
Different cancers, different biology. Sentinel lymph node concept with a primary gatekeeper node is not an accepted concept in all cancers. Finally many underpowered trials…
@VickersBiostats Similarly in cervical cancer RCTs of sentinel LN bx safer and similarly effective as PLND https://t.co/uXgPfUTnzT
0
1
14
Trials underway. More follow up needed to examine difference in MFS. Difference in BCR may not be the right endpoint. @DrSpratticus what is the true final position of the radiation literature on the topic?
@VickersBiostats It is reasonable (although not everyone agrees extended PLND data is conclusive and practice patterns would support this), but not always valid. If C is better than B, then C must be better than A. Not necessarily true. Good example of when this breaks down: In low risk PCa
1
0
6